<SEC-DOCUMENT>0001654954-20-014016-index.html : 20201230
<SEC-HEADER>0001654954-20-014016.hdr.sgml : 20201230
<ACCEPTANCE-DATETIME>20201230152107
ACCESSION NUMBER:		0001654954-20-014016
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20201224
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201230
DATE AS OF CHANGE:		20201230

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARILLO BIOSCIENCES INC
		CENTRAL INDEX KEY:			0001014763
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				751974352
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20791
		FILM NUMBER:		201425692

	BUSINESS ADDRESS:	
		STREET 1:		AMARILLO BIOSCIENCES INC
		STREET 2:		4134 BUSINESS PARK DRIVE
		CITY:			AMARILLO
		STATE:			TX
		ZIP:			79110-4225
		BUSINESS PHONE:		(806) 376-1741

	MAIL ADDRESS:	
		STREET 1:		AMARILLO BIOSCIENCES INC
		STREET 2:		4134 BUSINESS PARK DRIVE
		CITY:			AMARILLO
		STATE:			TX
		ZIP:			79110-4225
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>amar_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: amar_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>amar_ex2-1.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT DATED AS OF DECEMBER 24, 2020
<TEXT>
Document 2 - file: amar_ex2-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>amar_ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
Document 3 - file: amar_ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>